Cell therapy emerges as potential option for patients with acute myeloid leukemia facing relapse.
Discover the top abstracts of note for the 2023 ASH annual meeting.
New study yields clues to the cause of relapse after bone marrow transplant in patients with certain types of leukemia.
Children and young adults with acute lymphoblastic leukemia (ALL) who live more than 50 miles away from a treatment center face inferior survival outcomes, according to a recent study. Pediatric hematologist-oncologists Rabi Hanna, MD and Seth Rotz, MD, discuss the implications of their findings.